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Epidemiologic studies show an inverse correlation between garlic consumption and
progression of cardiovascular disease. However, the molecular basis for the beneficial
effect of garlic on the heart is not known. Therefore, the objective of the present study
was to (1) investigate the effect of raw garlic on isoproterenol (Iso) induced cardiac
hypertrophy (2) find the active metabolites of garlic responsible for the beneficial effect.
Cardiac hypertrophy was induced in rats by subcutaneous single injection of Iso 5 mg
kg−1 day−1 for 15 days and the effect of garlic (250 mg/kg/day orally) was evaluated.
Garlic metabolites in in vivo were identified by LC/MS study. The effect of garlic and its
metabolites were evaluated against hypertrophy in H9C2 cells. Garlic normalized cardiac
oxidative stress after Iso administration. Cardiac pathology and mitochondrial enzyme
activities were improved in hypertrophy heart after garlic administration. Decreased
Na+/K+-ATPase protein level that observed in hypertrophy heart was increased after
garlic administration. We identified three garlic metabolites in rat serum. To confirm
the role of garlic metabolites on cardiac hypertrophy, Na+/K+-ATPase expression and
intracellular calcium levels were measured after treating H9C2 cells with raw garlic and
two of its active metabolites, allyl methyl sulfide and allyl methyl sulfoxide. Raw garlic and
both metabolites increased Na+/K+-ATPase protein level and decreased intracellular
calcium levels and cell size in Iso treated H9C2 cells. This antihypertrophic effect of
garlic and its sulfur metabolites were lost in H9C2 cells in presence of Na+/K+-ATPase
inhibitor. In conclusion, garlic and its active metabolites increased Na+/K+-ATPase in
rat heart, and attenuated cardiac hypertrophy and associated remodeling. Our data
suggest that identified new garlic metabolites may be useful for therapeutic intervention
against cardiac hypertrophy.
Keywords: garlic, hypertrophy, Na+/K+-ATPase, isoproterenol, garlic-metabolites
Abbreviations: AMS, allyl methyl sulfide; AMSO, allyl methyl sulfoxide; AMSO2, allyl methyl sulfone; DPPH, 2,2-
Diphenylpicrylhydrazyl; GSH, Glutathion; H&E, hematoxylin and eosin; Iso, Isoproterenol; LDH, lactate dehydrogenase;
NCX, Na+/Ca2+ exchanger; PCR, Polymerase chain reaction; RPL32, Ribosomal protein L32; SGOT, serum glutamic
oxaloacetic transaminase; SOD, superoxide dismutase; β-MHC, β-Myosin Heavy Chain.
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INTRODUCTION
Hypertrophy followed by heart failure is a major health
problem of every nation. It is well recognized that causes
of hypertrophy are multifactorial. The most common risk
factors for cardiac hypertrophy are coronary heart disease,
high blood pressure, diabetes and idiopathic cardiomyopathy.
Cardiac hypertrophy is a cellular response and viewed as a
compensatory response to biochemical stress and haemodynamic
changes (Kang, 2006). Cardiac hypertrophy is a potent
risk factor for the development of cardiac arrhythmias,
diastolic dysfunction, congestive heart failure and death.
Sustained pathological hypertrophy is deleterious and may
leads to heart failure and death (Frey and Olson, 2003).
It is also a risk factor for QT prolongation and cardiac
sudden death. Therefore, it is very important to elucidate the
molecular mechanism and potent remedy to prevent cardiac
hypertrophy.
The intracellular factors that contribute to cardiac remodeling
include oxidative stress, mitochondrial dysfunction, reactive
oxygen species (ROS) generation and inflammation. One of the
features of cardiac remodeling is a progressive impairment in
mitochondrial function (Verdejo et al., 2012). The heart has a
large number of mitochondria, which form a complex network
under constant remodeling in order to sustain the high metabolic
rate of cardiac cells when oxygen supply is threatened. High
release of electrons from the electron transport chain leads
to ROS generation and mitochondrial dysfunction (Turrens,
2003).
Along with mitochondrial dysfunction and ROS generation,
expression of several signaling proteins altered that impaired
the cardiac function (Takimoto and Kass, 2007). Na+/K+-
ATPase is a major transporter for active ion transport across
the sarcolemma and thus play an important role in controlling
the electrical as well as the contractile function of the
myocardium. It was revealed that reduction of Na+/K+-ATPase
in the heart leads to contractile dysfunction, generation of
arrhythmias and heart failure (Schwinger et al., 2003). Thus,
augmentation or normalization of Na+/K+-ATPase level in
the heart through nutritional or pharmacological agent might
be responsible for attenuation of cardiac hypertrophy and
remodeling.
Garlic, (Allium sativum) is a perennial herb and abundant with
sulfur compounds. The role of garlic in reducing hyperlipidemia,
hypertension, and platelet aggregation have been well established
(Rahman and Lowe, 2006). Previously, garlic oil has been shown
to prevent cardiac hypertrophy in hypercholesterol-fed hamster
(Hsieh et al., 2014). The beneficial effect of garlic in heart might
be through activation of nitric oxide pathway. The role of garlic
to enhance nitric oxide production is well documented (Khatua
et al., 2012, 2016). Nitric oxide plays a crucial role to modulate
cardiac Na+/K+-ATPase activity (Pavlovic et al., 2013). However,
no study has been addressed to find the effect of raw garlic and
its metabolites on cardiac hypertrophy and Na+/K+-ATPase level
in heart. Therefore, we aim to determine the effect of raw garlic
and its metabolites on attenuation of cardiac hypertrophy in vitro
and/or in vivo by modulating Na+/K+-ATPase level.
MATERIALS AND METHODS
Garlic Homogenate
Garlic (A. sativum) bulbs were purchased from a local market.
Cloves were peeled, sliced, ground into a paste and then
suspended in distilled water. Rats were fed freshly prepared
aqueous garlic homogenate every day through esophagus by oral
gavage.
Animals
All animal experiments were undertaken with the approval
of Institutional Animal Ethics Committee of Indian Institute
of Chemical Technology (IICT), Hyderabad. All experiments
were performed in accordance with IICT guidelines and
regulations.
Experimental Protocol
Rat Model
Weight matched (200 g) male Sprague-Dawley rats were
randomly divided into three groups of eight rats each.
Experimental groups are described in Table 1. Control rats were
fed normal saline daily for 15 days. Aqueous garlic homogenate
was fed by oral gavage every day at a fixed time (10:00 AM)
for 15 days at a dose of 250 mg/kg. Two test groups (Iso and
Iso+Garlic) were given Iso subcutaneously every day at a fixed
time (10:00 AM) for 15 days at a dose of 5 mg/kg/day. At the
end of 15 days, 2 ml blood was aspirated from the left ventricle,
collected in a heparinized vial, centrifuged at 3000 g for 10 min
and the plasma was stored at −80◦C for estimation of plasma
LDH, SGOT, NO and H2S levels. At the end of 15 days, rats are
sacrificed and hearts were stored at −80◦C for estimation of all
other tissue parameters.
Cell Culture
H9C2 cell line is derived from embryonic rat heart tissue and
exhibits many morphological characteristics similar to those of
immature embryonic cardiomyocytes but has preserved several
elements of the electrical and hormonal signal pathway found
in adult cardiac cells. Therefore, this cell line was used in the
present study to induce hypertrophy (Hescheler et al., 1991).
H9C2 cells were purchased from ATCC, USA and cultured using
Dulbecco’s Modified Eagle Medium (DMEM) containing10%
fetal bovine serum (FBS). Cells from passages 2–7 were used
for all the experiments. Cells were seeded into a six-well plate
and allowed to proliferate until 70–80% confluence. Cells were
TABLE 1 | Experimental groups.
SL No Groups Description
1 Control Subcutaneous injection of normal saline daily
for 15 days.
2 Iso Subcutaneous injection of Iso 5 mg kg−1
day−1 for 15 days.
3 Iso+Garlic Oral administration of garlic homogenate
250 mg kg−1 day−1 for 15 days along with Iso
as administered in Iso group.
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treated with Iso (25 µM) for 48 h and then treated with fresh
aqueous garlic extract (0.25 mg/ml), AMS (100 nM/L) and
AMSO (100 nM/L) for 24 h. Cell size, an important parameter
of hypertrophy is measured. Protein was collected for western
blot analysis of Na+/K+-ATPase. To find the role of Na+/K+-
ATPase on hypertrophy in H9C2 cells, Digoxin (100 nM) (Ivana
et al., 2012) was pre-treated along with Iso for 48 h followed by
24 h treatment of Garlic and its metabolites (AMS and AMSO).
More details of this experiment were given in the Supplementary
File.
Measurement of Intracellular Calcium in
H9C2 Treated Cells
After 70% confluency, H9C2 cells were treated with Iso, garlic and
its metabolites. After 48 h of treatment, media was discarded and
cells were loaded with 1 µM Fura 2-AM in phosphate buffer for
45 min at 37◦C. Dye was removed and cells were washed with
PBS two times. The cells were suspended in phosphate buffer
and centrifuged. Then cell pellet was resuspended and lysed
with RIPA buffer. Then fluorescence was measured at excitation
spectra at 340/380 nm with emission at 510 nm. Intracellular free
calcium was expressed in terms of percentage of fluorescence per
microgram protein.
Measurement of Garlic Metabolites by
U-HPLC-MS Study
We used U-HPLC-MS method for separation of garlic
metabolites. In brief, six adult male Sprague-Dawley rats
were administered (250 mg/kg of garlic homogenate) orally for
15 days. The blood samples were collected at 15 min, 30 min,
1, 2, 4, 6, 8, and 10 h. Blood samples were pooled together
to generate a single sample of matrix. Pooled samples were
thoroughly vortex and centrifuged at 5000 rpm for 15 min
at 4◦C; and plasma was collected and stored at −20◦C until
analysis. Samples were prepared by simple protein precipitation
method.
Cardiac Hypertrophy
Daily subcutaneous single injection of Iso at a dose of 5 mg/kg
body weight for 15 days creates cardiac hypertrophy in rats
(Alderman and Harrison, 1971; Osadchii, 2007). In each group,
the heart weight/body weight ratio and β MHC gene expression
in heart were measured as indicators of cardiac hypertrophy.
Serum Parameters
Plasma SGOT and LDH were estimated as markers of cardiac
injury. SGOT, LDH activity and nitric oxide were estimated
by according to the method described by (Khatua et al.,
2012). Myocardial H2S concentration was measured from heart
homogenate as described by Sojitra et al. (2012).
Myocardial Conjugated Dienes Level and
Antioxidant Status
Myocardial conjugated dienes is a measure for membrane lipid
peroxidation and were estimated according to the method
described by Devasagayam et al. (2003). Myocardial GSH
content, SOD activities and myocardial catalase activity in heart
homogenate were measured by the method as described (Gupta
et al., 2013). Total antioxidant activity was measured by DPPH
assay as described earlier (Khatua et al., 2012).
Mitochondrial Enzyme Activity in Heart
Activities of mitochondrial enzymes, e.g., citrate synthase and β
hydroxyacyl CoA dehydrogenase and cytochrome C oxidase were
estimated to measure the extent of mitochondrial dysfunction.
These enzymes were measured according to the method
described by Civitarese et al. (2007).
Immunoblot Analysis
Total protein extraction and immunoblotting were performed
as described previously (Banerjee et al., 2009). Protein
concentration was determined by Bradford method. An
equal amount (40 µg) of protein was separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS–
PAGE). After electrophoresis, protein was transferred to PVDF
membranes (Millipore, USA). The membranes were then
blocked in Tris-buffered saline Tween-20 (TBS-T; 10 mM Tris,
pH 7.5, 150 mM NaCl, 0.05% Tween-20) and 5% non-fat dry
milk for 1 h, and subsequently washed and incubated with
primary antibodies in TBST with 3% non-fat dry milk at 4◦C
for overnight. The following polyclonal antibody and titer was
used: Na+/K+-ATPase (1:1,000, Cell Signaling Technology
# 3010), After washing with TBS-T, membrane was incubated
with Goat Anti-Rabbit IgG– HRP (1:4000 dilution, Cell
Signaling Technology, # SC 2004) horseradish peroxidase
conjugated secondary antibody with 2.5% non-fat dry milk
at room temperature for 2 h. After washing with TBS-T
immunoreactions were visualized with a chemiluminescence
detection kit (Prod No- 34080, Super signal R© west Pico
chemiluminescent substrate, Thermo Scientific). Then the blots
were exposed to X- ray film (Hyperfilm ECL, GE Healthcare,
USA) and developed. Gel stained with coomassie blue served
as an equal loading control. Quantification of band intensity
was performed using the Image J Software (NIH, Bethesda,
MD, USA). For bar graph generation of Na+/K+-ATPase,
the density of bands was obtained from two independent
western blots runs under the same experimental conditions.
Gel stained with coomassie blue served as an equal loading
control.
Gene Expression
Total RNA was extracted from the whole heart with Trizol
(Sigma) and cDNA was prepared according to the method
described by Banerjee et al. (2009). PCR was performed for
collagen I, RPL32 and β-MHC mRNA expression. Rat collagen
I forward primer (5′-ACGTCCTGGTGAAGTTGGTC-3′)
and reverse primer (5′-CAGGGAAGCCTCTTTCTCCT-3′),
RPL32 forward primer 5′-AGATTCAAGGGCCAGATCCT-3′
and reverse primer 5′-CGATGGCTTTTCGGTTCTTA-3′),
β-MHC forward primer 5′-TGGAGCTGATGCACCTGTAG-3′
and reverse primer 5′- ACTTCGTCTCATTGGGGATG-3′,
BAX forward primer 5′-TGCAGAGGATGATTGCGACT-3′ and
reverse primer 5′-GATCAGCTCGGGCACTTTAG-3′, Caspase 3
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forward primer 5′-AGGCCGACTTCCTGTATGCT-3′ and
reverse primer 5′-TCCGGTTAACACGAGTGAGG-3′, and BAD
forward primer 5′-AGTGAGCAGGAAGACGCTAG-3′ and
reverse primer 5′-TAAGCTCCTCCTCCATCCCT-3′.
Histopathology
Masson’s Trichrome is commonly used for staining collagen and
detecting cardiac fibrosis. Heart tissue was fixed in 10% formalin,
routinely processed and embedded in paraffin. Paraffin sections
(3 µm) were cut on glass slides, stained with Masson’s Trichrome
and examined under a light microscope to find myocardial
fibrosis. Two sections of heart from each group were analyzed for
histopathology in a blinded manner.
Statistical Analysis
All values were expressed as mean± SEM. Data were statistically
analyzed using one-way ANOVA for multiple group comparison
followed by Bonferroni post hoc test. Significance was set at
p< 0.05.
RESULTS
Garlic Treatment Attenuated Cardiac
Hypertrophy in Rat Heart
Heart weight/Body weight ratio and β-MHC gene expression
were measured as markers of cardiac hypertrophy. These were
significantly (p < 0.05) increased in Iso group compared to
control group and significantly (p< 0.05) decreased in Iso+garlic
group compared to Iso group (Figures 1A,B).
Garlic Treatment Reduced Cardiac Injury
Parameters and Normalized Serum NO
and H2S Level
Serum SGOT and LDH are two important serum markers for
cardiac injury. A significant (p < 0.05) increase in both SGOT
and LDH levels was observed in Iso group compared to control.
However, a significant (p < 0.05) decrease in both SGOT and
LDH levels was observed in Iso+garlic group in comparison to
Iso group (Figures 2A,B).
On the other hand nitric oxide and hydrogen sulfide, two
endogenous gaseous molecules of endothelial cells are protective
indicators of the cardiac system. There were significant (p< 0.05)
decrease in serum NO metabolites and hydrogen sulfide levels
in Iso group compared to control group. However, a significant
(p < 0.05) increase in serum NO metabolites and hydrogen
sulfide levels was observed in Iso+garlic group compared to Iso
group (Figures 2C,D).
Garlic Treatment Attenuated Oxidative
Stress in Hypertrophy Rat Heart
A significant (p < 0.05) decrease in myocardial GSH level,
catalase and SOD activity and total antioxidant capacity was
observed in Iso group compared to control group. However,
a significant (p < 0.05) increase in these myocardial enzymes
activity was observed in Iso+garlic group compared to Iso group
(Figures 3A–C,E).
A significant (p < 0.05) increase in myocardial conjugated
diene levels was observed in Iso group compared to control
group. However, there was significant (p < 0.05) decrease in
myocardial conjugated diene levels observed in Iso+garlic group
compared to Iso group (Figure 3D).
Garlic Treatment Enhanced
Mitochondrial Enzymes Activity in
Hypertrophy Heart
Mitochondrial enzymes in the heart are affected during
hypertrophy and heart failure condition. Citrate synthase, β
hydroxyacyl CoA dehydrogenase and cytochrome C oxidase
are key mitochondrial enzymes involved in the Krebs cycle,
β-oxidation, and electron transport chain activities, respectively.
A significant (p < 0.05) decrease in these enzyme activities was
observed in Iso group compared to control group. However,
a significant (p < 0.05) increase in the activity of all those
enzymes was observed in Iso+garlic group compared to Iso
group (Figures 4A–C).
Garlic Treatment Reduced Collagen
Gene Expression and Normalized
Histopathological Changes in
Hypertrophy Heart
Collagen-I mRNA expression is a marker of myocardial fibrosis.
Collagen-I is the most abundant among all types of collagens.
There was significant (p < 0.05) increase in collagen-I gene
expression in Iso group compared to control group. However,
a significant (p < 0.05) decrease in collagen-I gene expression
was observed in Iso+garlic group compared to Iso group
(Figures 5A,B). We have also looked gene expression of three
apoptotic markers, i.e., Bax, Bad, and caspase 3 in H9C2 cells
after Iso treatment and co-treatment with garlic and sulfur
metabolites. There was no significant alteration of these genes
between control and iso group (Supplementary Figure S2).
We observed myocardial fibrosis in Iso group after staining
with Masson’s trichrome. While light micrograph of control
heart showed normal architecture and no fibrosis, hypertrophic
heart (Iso) showed massive fibrosis in cardiac muscle along with
infiltration of acute and chronic inflammatory cells. However, our
finding showed that fibrosis, as well as myocardial injury, was
reduced after garlic treatment (Iso+garlic group) (Figure 5C).
Allyl methyl Sulfide (AMS), Allyl Methyl
Sulfoxide (AMSO) and Allyl Methyl
Sulfone AMSO2 Are Most Abundant
Garlic Metabolites Present in Serum
after Oral Administration of Garlic
Homogenate
The metabolites of garlic homogenate were detected after oral
administration of raw garlic in rats. The identified metabolites
of garlic in rat plasma are AMS, AMSO and AMSO2. Figure 6
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FIGURE 1 | Effect of garlic on Iso-induced cardiac hypertrophy. (A) Heart weight and body weight ratio. (B) Expression of β-MHC mRNA. Data were shown as
mean ± SEM (N = 6), ∗p < 0.05 vs. Control, #p < 0.05 vs. Iso.
FIGURE 2 | Effect of garlic on cardiac injury parameters. (A) Serum SGOT. (B) Serum LDH. (C) Serum nitric oxide. (D) Serum hydrogen sulfide. (N = 6). Data
were shown as mean ± SEM, ∗p < 0.05 vs. Control, #p < 0.05 vs. Iso.
shows the U-HPLC/APCI-HRMS-EIC metabolites of garlic
homogenate formed in the plasma. To elucidate the structures
of the metabolites, the [M+H]+ ions of allyl methyl sulphoxide
and AMSO2 by using U-HPLC-APCI-HRMS experiments in
combination with accurate mass measurements was studied.
Three compounds were identified by comparing their retention
times and or mass spectra with those of synthesized standard
compounds (Figures 6A–C; Table 2).
Garlic and Its Metabolites Attenuated
Cell Size and Intracellular Calcium Level
in H9C2 Cells
In hypertrophy, the rate of protein synthesis generally increases.
Therefore, the cross-sectional area of cardiac cells, i.e., cell size
is a marker of cardiac hypertrophy. There was a significant
(p < 0.01) increase in cell size in Iso group in comparison to
control group. However, a significant (p < 0.01) decrease in cell
size was observed in garlic and its metabolites treated groups
compared to Iso group (Figures 7A,B). Similarly, intracellular
calcium concentration was increased significantly (p < 0.05) in
Iso group and decreased (p< 0.05) after garlic and its metabolites
treatment (Figure 7C).
Improvement of Na+/K+-ATPase in
Hypertrophy Heart and H9C2 Cells after
Garlic and Its Metabolites Treatment
Na+/K+-ATPase is an important enzyme of heart contraction.
Prolong inhibition of this enzyme creates hypertrophy and heart
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FIGURE 3 | Effect of garlic on endogenous antioxidants, conjugated dienes and total antioxidants. (A) Myocardial GSH. (B) Myocardial catalase.
(C) Myocardial super oxide dismutase. (D) Myocardial conjugated diene. (E) Myocardial total antioxidant capacity. (N = 6). Data were shown as mean ± SEM,
∗p < 0.05 vs. Control, #p < 0.05 vs. Iso.
failure. To find the effect of garlic and its metabolites on Na+/K+-
ATPase protein levels, we did immunoblotting from heart and
H9C2 cell. No change in Na+/K+-ATPase protein expression
levels was observed in H9C2 cells treated with Iso compared
to control cells. However, a significant (p < 0.05) increase in
Na+/K+-ATPase levels was observed in garlic and two garlic
metabolites treated groups (Figures 8A,B).
A significant (p < 0.05) decrease in Na+/K+-ATPase protein
levels was observed in Iso group compared to control group.
However, a significant (p < 0.05) increase Na+/K+-ATPase
expression was observed in Iso+garlic group compared to Iso
group (Figures 8C,D).
Garlic and Its Metabolites Failed to Show
Any Anti-Hypertrophic Effect in H9C2
Cells in Presence of Na+/K+-ATPase
Inhibitor
To confirm whether garlic and its metabolites showed their anti-
hypertrophic effect through Na+/K+-ATPase, we treated H9C2
cells with Iso in presence and absence of digoxin, a Na+/K+-
ATPase inhibitor. There was an increase (p < 0.05) of cell size in
iso group and iso+digoxin groups. However, garlic as well as two
metabolites (AMS and AMSO) failed to attenuate the Iso-induced
hypertrophic effect in presence of digoxin (Supplementary Figure
S1).
DISCUSSION
The present study revealed that garlic protects against cardiac
hypertrophy by inhibiting oxidative stress and improving
mitochondrial efficiency. Our finding supported that garlic could
be a promising nutritional agent for therapies against cardiac
hypertrophy and remodeling. Stimulation of the β-adrenoceptors
by Iso is a well-known animal model of cardiac hypertrophy
without systolic hypertension (Galindo et al., 2009). Iso induces
myocardial hypertrophy as well as injury in rats through several
mechanisms, including oxidative stress, ROS generation, an
increase in collagen deposition, intracellular calcium overload,
inflammation and exhaustion of high-energy phosphates through
reduction of mitochondrial efficiency (Sharma et al., 2010).
Excess free radical production in the heart after Iso may
cause necrosis, loss of contractile tissue, fibrosis and severe
arrhythmias. All those changes in heart ultimately induce cardiac
hypertrophy and remodeling with dilatation over time in rats.
There are several natural or nutritional agents that were used
previously to reduce oxidative stress in heart and improved
cardiac health. Among them, garlic attracted more scientific
attention for its beneficial effect against cardiovascular disorder
(Banerjee and Maulik, 2002). Although, attenuation of cardiac
hypertrophy after allicin administration was observed (Liu et al.,
2010), the active component responsible for this beneficial effect
was not clear. In the present study, we administered raw garlic
homogenate, rich in allicin, in rats and identified the active garlic
metabolites through LC/APCI/HRMS study. Our data showed
that raw garlic was effective to reduce cardiac hypertrophy
and associated remodeling in the heart through those active
metabolites.
The previous study reported that oxidative stress plays
an important role to develop cardiac hypertrophy and its
progression to heart failure. Sustained β-AR activation was
shown to promote oxidative stress in cardiac myocytes as
evidenced by increased lipid peroxidation as well as decreased
endogenous antioxidant (Rehsia and Dhalla, 2010). Similarly, our
data also showed a significant increase in lipid peroxidation as
observed by a higher level of conjugated dienes and decrease
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FIGURE 4 | Effect of garlic on mitochondrial enzyme activity. (A) Citrate
synthase activity (B) β-hydroxylacyl CoA dehydrogenase (C) Cytochrome C
oxidase activity. (N = 6). Data were shown as mean ± SEM, ∗p < 0.05 vs.
Control, #p < 0.05 vs. Iso.
in endogenous antioxidants like SOD, catalase and GSH in rat
heart after Iso treatment. Increased oxidative stress as observed
in our study might be due to overproduction of free radical
and ROS. Alteration of mitochondrial efficiency during disease
condition may enhance ROS generation. Mitochondria, which
occupy a large portion of the myocyte play a crucial role to
supply energy to the heart. Scientific evidence suggests that
mitochondria play an important role in the progression and
development of heart disease (Ide et al., 1999). The scientific
literature showed that alterations in mitochondrial function are
involved in the decompensation of cardiac hypertrophy. In the
present study, we focused on changes in mitochondrial enzymes
activities and alteration of oxidative stress during hypertrophy.
Our data indicated that mitochondrial enzymes like citrate
synthase, beta hydroxyl acyl CoA dehydrogenase and cytochrome
c oxidase were decreased in Iso-treated heart. However, all those
three enzymes increased significantly after garlic administration.
Increased myocardial fibrosis and collagen deposition is
a hallmark of cardiac hypertrophy (Ho et al., 2010). It is
mostly due to secondary response to the pathophysiological
remodeling of long-standing disease. In the present study, we
observed a significant increase in collagen-I mRNA expression
and fibrosis in Iso-treated heart. However, administration of
garlic normalized the higher collagen-I expression and fibrosis
in Iso-treated heart. Along with collagen synthesis, increased
myocytes injury was observed in Iso-treated heart and decreased
significantly after garlic treatment.
Gaseous molecules were determined in the present study to
understand the protective effect of garlic on cardiac hypertrophy.
Nitric oxide signaling declines during cardiac hypertrophy
(Zhang et al., 2012). Inhibition of nitric oxide synthesis increases
cardiac hypertrophy and fibrosis in rat’s subjected to aerobic
training (Souza et al., 2007). Similar to nitric oxide, hydrogen
sulfide also plays an important role in cardiac hypertrophy.
Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis
induced by abdominal aortic coarctation in rats (Huang et al.,
2012). Plasma high hydrogen sulfide concentration may enhance
cardioprotection (Wang et al., 2011). Similar to previous studies,
we also observed a significant reduction of myocardial NO and
H2S level. However, raw garlic administration normalized those
two important gaseous molecules.
Although we have observed a significant reduction of
cardiac hypertrophy, the molecular mechanism and the active
metabolites of garlic responsible for this beneficial effect is
not well-understood. Allicin, the main active ingredients of
garlic homogenate, was not present in the blood after oral
consumption of raw garlic homogenate. Therefore, it was very
important to identify the active metabolites of garlic in vivo.
We identified three sulfur compounds by LC-MS study from
rat plasma after oral administration of raw garlic. These three
compounds are AMS and AMSO, AMSO2. To confirm the
anti-hypertrophic effect of those metabolites, we treated H9C2
cells (cardiomyocytes) with raw garlic and two of its active
metabolites, AMS and AMSO. Several research papers also used
this H9C2 cells as one of the cell lines to validate many in vivo
data. Although there are limitations of this cell line for certain
cardiac activity especially contraction and relaxation, this cell
was extensively used for inducing hypertrophy to look cellular
signaling pathways (Jeong et al., 2009). Our data confirmed that
raw garlic homogenate as well as two garlic metabolites, AMS and
AMSO significantly decreased the cell size.
The molecular mechanism by which garlic and its metabolites
reduced cardiac hypertrophy might be several. Our data found
that garlic and its two metabolites can enhance Na+/K+-ATPase
level in heart and H9C2 cells. Prolong inhibition of Na+/K+-
ATPase or reduction of Na+/K+-ATPase levels in the heart
results in progressive accumulation of intracellular Na+ ion
which indirectly results in intracellular Ca2+ accumulation.
Na+/K+ pump efficiently couple to Na+/Ca2+ exchanger
(NCX) to maintain Ca2+ ion regulation. (Shattock et al.,
2015). Low Na+/K+-ATPase levels or activity promote Ca2+
influx via NCX leading to Ca2+ accumulation which can
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FIGURE 5 | Effect of garlic on collagen-I expression and myocardial injury after Iso administration. (A) Myocardial collagen-I mRNA expression. (B) Bar
graph of collagen-I expression. (C) Fibrosis as observed by Masson’s Trichrome stain (scale bar 200 µm). Data were shown as mean ± SEM (N = 3), ∗p < 0.05 vs.
Control, #p < 0.05 vs. Iso.
FIGURE 6 | U-HPLC/APCI-MS-EIC of (A) allyl methyl sulfide (m/z 89, Rt-3.78 min). (B) Allyl methyl sulphoxide (m/z 105,Rt = 2.26 min). (C) Allyl methyl
sulfone(m/z 121,Rt = 5.00 min).
TABLE 2 | Elemental compositions for garlic components obtained after LC-MS study.
Metabolites Formula Observe mass (Da) Calculated mass (Da) Error (ppm)
Allyl methyl sulfide C4H9S 89.04277 89.04250 −3.03
Allyl methyl sulphoxide C4H9SO 105.03692 105.03741 4.67
Allyl methyl sulfone C4H9SO2 121.03201 121.03233 2.64
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FIGURE 7 | Effect of garlic and its metabolites on hypertrophy of H9C2 cells. (A) Images of H9C2 cells to measure cell size. (B) Bar diagram of cell sizes.
(C) Intracellular calcium level in H9C2 cells. (N = 20). Data were shown as mean ± SEM, ∗p < 0.05 vs. Control, #p < 0.05 vs. Iso.
FIGURE 8 | Effect of garlic and its metabolites on Na+/K+-ATPase expression. (A,B) Western blot and bar graph of Na+/K+-ATPase from H9C2 cells. (C,D)
Western blot and bar graph of Na+/K+-ATPase from rat heart. (Gels and blots were cropped and run under same experimental conditions). (N = 3). Data were
shown as mean ± SEM, ∗p < 0.05 vs. Control, #p < 0.05 vs. Iso (2).
accelerate myocardial necrosis, contractile failure and also trigger
arrhythmias. Calcium overload is one of the mechanisms of
Iso-induced cardiac hypertrophy and heart failure (Garg and
Khanna, 2014) and also observed in our Iso treated H9C2
cells. Specifically, in cardiac hypertrophy, many studies have
shown that Na+/K+ pump function, and/or expression, is
reduced. The Na+/K+-ATPase activity in rat sarcolemma after
Iso-induced myocarditis decreases by 42% (Osadchaia et al.,
1990). Thus, a correlation between the decrease in heart
function and the decrease in Na+/K+-ATPase concentration
exists (Schwinger et al., 2003). In a failure heart, ventricular
weight was markedly increased along with the significant
reduction of Na+/K+-ATPase activity (Yazaki and Fujir,
1972). In the present study, we have observed a significant
decrease of Na+/K+-ATPase protein level in hypertrophy
heart. Therefore, it could be possible that Ca+2 overload
due to lower Na+/K+-ATPase level might be the major
contributor for cardiac hypertrophy in our rat model. However,
garlic treatment normalized the Na+/K+-ATPase level in Iso-
treated hypertrophy heart and thus may reduce the Ca+2
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overload. Our data confirmed that garlic and both metabolites
AMS and AMSO have a property to increase Na+/K+-ATPase
protein level and decrease intracellular calcium level, and thus
have ability to attenuate cardiac hypertrophy. Reduction of
cardiac hypertrophy by garlic and its metabolites is summarized
in the graphical abstract.
CONCLUSION
Garlic and its identified metabolites could prevent Iso-induced
hypertrophic growth in rat heart and H9C2 cells though partially
increased Na+/K+-ATPase level. Identified and characterized
garlic metabolites viz. AMS and AMSO could be developed as
potential drug molecules against cardiac hypertrophy.
AUTHOR CONTRIBUTIONS
TK and SB designed the research. TK, AD, SM, RB, RS, and SB
performed experiments and analyzed data. TK and SB wrote the
manuscript and had full access to all the data in the study and take
responsibility for the integrity of the data and the accuracy of the
data analysis.
ACKNOWLEDGMENTS
Financial support was provided by Ramalingaswami Fellowship
fund (SKB) from Department of Biotechnology (DBT), Senior
Research Fellowship (TK and RB) from Council of Scientific
and Industrial Research (CSIR) Government of India, and grant
support from Department of Science and Technology (DST)
(SR/SO/HS-110/ 2008) and CSIR (Thunder, BSC0102).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fphar.
2017.00018/full#supplementary-material
REFERENCES
Alderman, E. L., and Harrison, D. C. (1971). Myocardial hypertrophy resulting
from low dosage isoproterenol administration in rats. Exp. Biol. Med. 136,
268–270. doi: 10.3181/00379727-136-35243
Banerjee, S. K., and Maulik, S. K. (2002). Effect on garlic on
cardiovascular disorders: a review. Nutr. J. 1, 1–14. doi: 10.1186/1475-
2891-1-4
Banerjee, S. K., McGaffin, K. R., Pastor-Soler, N. M., and Ferhaan, A. (2009).
SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states.
Cardiovasc. Res. 84, 111–118. doi: 10.1093/cvr/cvp190
Civitarese, A. E., Carling, S., Heilbronn, L. K., Hulver, M. H., Ukropcova, B.,
Deutsch, W. A., et al. (2007). Calorie restriction increases muscle mitochondrial
biogenesis in healthy humans. PLoS Med. 4:e76. doi: 10.1371/journal.pmed.
0040076
Devasagayam, T. P. A., Boloor, K. K., and Ramasarma, T. (2003). Methods
for estimating lipid peroxidation: an analysis of merits and demerits. Ind. J.
Biochem. Biophys. 40, 300–308.
Frey, N., and Olson, E. N. (2003). Cardiac hypertrophy: the good, the bad, and the
ugly. Annu. Rev. Physiol. 65, 45–79. doi: 10.1146/annurev.physiol.65.092101.
142243
Galindo, C. L., Skinner, M. A., Errami, M., Olson, L. D., Watson, D. A.,
Li, J., et al. (2009). Transcriptional profile of isoproterenol-induced
cardiomyopathy and comparison to exercise-induced cardiac hypertrophy
and human cardiac failure. BMC Physiol. 9:23. doi: 10.1186/1472-
6793-9-23
Garg, M., and Khanna, D. (2014). Exploration of pharmacological interventions
to prevent isoproterenol-induced myocardial infarction in experimental
models. Ther. Adv. Cardiovasc. Dis. 8, 155–169. doi: 10.1177/175394471
4531638
Gupta, P., Kanwal, A., Putcha, U. K., Bulani, Y., Sojitra, B., Khatua, T. N., et al.
(2013). Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol
induced myocardial necrosis: a new therapeutic implication. J. Trans. Med. 11,
1–6. doi: 10.1186/1479-5876-11-80
Hescheler, J., Meyer, R., Plant, S., Krautwurst, D., Rosenthal, W., Schultz, G., et al.
(1991). Morphological, biochemical, and electrophysiological characterization
of a clonal cell (H9C2) line from rat heart. Circ. Res. 69, 1476–1486. doi:
10.1161/01.RES.69.6.1476
Ho, C. Y., López, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim,
C. G. C. P., et al. (2010). Myocardial fibrosis as an early manifestation of
hypertrophic cardiomyopathy. N. Engl. J. Med. 363, 552–563. doi: 10.1056/
NEJMoa1002659
Hsieh, Y. L., Pai, P., Ho, T. J., Chung, L. C., Cheng, Y. C., Wu, C. H., et al.
(2014). Effects of garlic oil on interleukin-6 mediated cardiac hypertrophy in
hypercholesterol-fed hamsters. Chin. J. Physiol. 57, 320–328. doi: 10.4077/CJP.
2014.BAC261
Huang, J., Wang, D., Zheng, J., and Huang, X. J. (2012). Hydrogen sulfide
attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic
coarctation in rats. Mol. Med. Rep. 5, 923–928. doi: 10.3892/mmr.2012.748
Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., et al. (1999).
Mitochondrial electron transport complex I is a potential source of oxygen free
radicals in the failing myocardium. Circ. Res. 85, 357–363. doi: 10.1161/01.RES.
85.4.357
Ivana, C., Valentina, S., Joanna, K., Christian, L., Nico, M., Costanzo, C., et al.
(2012). Digoxin and ouabain induce the eﬄux of cholesterol via liver X receptor
signaling and the synthesis of ATP in cardiomyocytes. Biochem. J. 447, 301–311.
doi: 10.1042/BJ20120200
Jeong, K., Kwon, H., Min, C., and Pak, Y. (2009). Modulation of the caveolin-3
localization to caveolae and STAT3 to mitochondria by catecholamine-induced
cardiac hypertrophy in H9c2 cardiomyoblasts. Exp. Mol. Med. 41, 226–235.
doi: 10.3858/emm.2009.41.4.025
Kang, Y. J. (2006). Cardiac hypertrophy: a risk factor for qt-prolongation
and cardiac sudden death. Toxicol. Pathol. 34, 58–66. doi: 10.1080/
01926230500419421
Khatua, T. N., Dinda, A. K., Putcha, U. K., and Banerjee, S. K. (2016). Diallyl
disulfide ameliorates isoproterenol induced cardiac hypertrophy activating
mitochondrial biogenesis via eNOS-Nrf2-Tfam pathway in rats. Biochem.
Biophys. Rep. 2016, 77–88.
Khatua, T. N., Padiya, R., Karnewar, S., Kuncha, M., Agawane, S. B., Kotamraju, S.,
et al. (2012). Garlic provides protection to mice heart against isoproterenol-
induced oxidative damage: role of nitric oxide. Nitric Oxide 27, 9–17. doi:
10.1016/j.niox.2012.03.004
Liu, C., Cao, F., Tang, Q. Z., Yan, L., Dong, Y. G., Zhu, L. H., et al. (2010).
Allicin protects against cardiac hypertrophy and fibrosis via attenuating
reactive oxygen species-dependent signalling pathways. J. Nutr. Biochem. 21,
1238–1250. doi: 10.1016/j.jnutbio.2009.11.001
Osadchaia, L. M., Mugula, Z., and Stefanov, V. E. (1990). The beta-adrenergic
regulation of the Na. K-ATPase activity in the sarcolemma of the heart muscle.
Nauchnye Doki Vyss Shkoly Biol. Nauki 6, 138–147.
Osadchii, O. E. (2007). Cardiac hypertrophy induced by sustained
β-adrenoreceptor activation: pathological acpects. Heart Fail Res. 12, 66–86.
doi: 10.1007/s10741-007-9007-4
Pavlovic, D., Hall, A. R., Kennington, E. J., Aughton, K., Boguslavskyi, A.,
Fuller, W., et al. (2013). Nitric oxide regulates cardiac intracellular Na+ and
Frontiers in Pharmacology | www.frontiersin.org 10 January 2017 | Volume 8 | Article 18
fphar-08-00018 January 25, 2017 Time: 15:36 # 11
Khatua et al. Garlic Attenuates Cardiac Hypertrophy through Na+/K+-ATPase
Ca2+ by modulating Na/K ATPase via PKCε and phospholemman-dependent
mechanism. J. Mol. Cell Cardiol. 61, 164–171. doi: 10.1016/j.yjmcc.2013.04.013
Rahman, K., and Lowe, G. M. (2006). Garlic and cardiovascular diseases: a critical
review. J. Nutr. 136, 736S–740S.
Rehsia, N. S., and Dhalla, N. S. (2010). Mechanisms of the beneficial effects of
betaadrenoceptor antagonists in congestive heart failure. Exp. Clin. Cardiol. 15,
e86–e95.
Schwinger, R. H. G., Bundgaard, H., Muller-Ehmsen, J., and Kjeldsen, K. (2003).
The Na+/K+-ATPase in the failing human heart. Cardiovasc. Res. 57, 913–920.
doi: 10.1016/S0008-6363(02)00767-8
Sharma, A., Mediratta, P. K., Sharma, K. K., and Fahim, M. (2010). Lipotab,
a polyherbal formulation, attenuates isoprenaline-induced left ventricular
remodeling and heart failure in rats. Hum. Exp. Toxicol. 30, 1000–1008. doi:
10.1177/0960327110384529
Shattock, M. J., Ottolia, M., Bers, D. M., Blaustein, M. P., Boguslavskyi, A.,
Bossuyt, J., et al. (2015). Na+/Ca2+ exchange and Na+/K+-ATPase in the
heart. J. Physiol. 593. 6, 1361–1382. doi: 10.1113/jphysiol.2014.282319
Sojitra, B., Bulani, Y., Putcha, U. K., Kanwal, A., Gupta, P., Kuncha, M., et al.
(2012). Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced
cardioprotection in mice. Mol. Cell Biochem. 360, 61–69. doi: 10.1007/s11010-
011-1044-6
Souza, H. C. D., Penteado, D. M. D., Martin-Pinge, M. C., Neto, O. B., Teixeira,
V. P. A., Blanco, J. H. D., et al. (2007). Nitric oxide synthesis blockade increases
hypertrophy and cardiac fibrosis in rats submitted to aerobic training.Arq. Bras.
Cardiol. 89, 88–93.
Takimoto, E., and Kass, D. A. (2007). Role of oxidative stress in cardiac hypertrophy
and remodeling. Hypertension 49, 241–248. doi: 10.1161/01.HYP.0000254415.
31362.a7
Turrens, J. F. (2003). Topical review-mitochondrial formation of reactive
oxygen species. J. Physiol. 552.2, 335–344. doi: 10.1113/jphysiol.2003.04
9478
Verdejo, H. E., del Campo, A., Troncoso, R., Gutierrez, T., Toro, B., Quiroga, C.,
et al. (2012). Mitochondria, myocardial remodeling, and cardiovascular disease.
Curr. Hypertens. Rep. 14, 532–539. doi: 10.1007/s11906-012-0305-4
Wang, X., Wang, Q., Guo, W., and Zhu, Y. Z. (2011). Hydrogen sulfide attenuates
cardiac dysfunction in a rat model of heart failure: a mechanism through
cardiac mitochondrial protection. Biosci. Rep. 31, 87–98. doi: 10.1042/BSR20
100003
Yazaki, Y., and Fujir, J. (1972). Depressed Na+/K+-ATPase activity in the failing
rabbit heart. Jpn. Heart J. 13, 73–83. doi: 10.1536/ihj.13.73
Zhang, M., Takimoto, E., Lee, D., Santos, C. X. C., Nakamura, T., Hsu, S., et al.
(2012). Pathological cardiac hypertrophy alters intracellular targeting of PDE5
from nitric oxide synthase-3 to natriuretic peptide signaling. Circulationaha
112, 942–951. doi: 10.1161/CIRCULATIONAHA.112.090977
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Khatua, Borkar, Mohammed, Dinda, Srinivas and Banerjee. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Pharmacology | www.frontiersin.org 11 January 2017 | Volume 8 | Article 18
